• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立稳定 _AML 小鼠模型的方案。

Protocol to establish a stable _AML mouse model.

机构信息

Department of Pharmacology and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China; Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, Zhejiang 311121, China; Institute of Hematology, Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, Zhejiang 310003, China.

Department of Pharmacology and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China; Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, Zhejiang 311121, China; Institute of Hematology, Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, Zhejiang 310003, China.

出版信息

STAR Protoc. 2022 Jul 18;3(3):101559. doi: 10.1016/j.xpro.2022.101559. eCollection 2022 Sep 16.

DOI:10.1016/j.xpro.2022.101559
PMID:35874469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9304668/
Abstract

Acute myeloid leukemia (AML) is one of the most common and fatal forms of hematopoietic malignancies. Here, we describe a mouse _AML model to investigate AML. We have optimized the protocols for retrovirus infection, bone marrow transplantation (BMT), and leukemia monitoring to create a stable mouse model. In particular, we have used two rounds of BMT to enhance stability and efficiency. This model can be used to conduct drug administration and/or other interventions easily. For complete details on the use and execution of this protocol, please refer to Zhao et al. (2022).

摘要

急性髓系白血病(AML)是最常见和致命的血液系统恶性肿瘤之一。在这里,我们描述了一种用于研究 AML 的小鼠 AML 模型。我们已经优化了逆转录病毒感染、骨髓移植(BMT)和白血病监测的方案,以创建一个稳定的小鼠模型。特别是,我们使用了两轮 BMT 来提高稳定性和效率。该模型可用于方便地进行药物给药和/或其他干预。有关此方案的使用和执行的完整详细信息,请参阅 Zhao 等人(2022 年)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8596/9304668/ebfced2e1f54/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8596/9304668/7cabf9390427/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8596/9304668/40d6d04a2a0e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8596/9304668/58aa116f082f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8596/9304668/5762c2cb3395/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8596/9304668/f5631ecdf588/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8596/9304668/ebfced2e1f54/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8596/9304668/7cabf9390427/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8596/9304668/40d6d04a2a0e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8596/9304668/58aa116f082f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8596/9304668/5762c2cb3395/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8596/9304668/f5631ecdf588/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8596/9304668/ebfced2e1f54/gr5.jpg

相似文献

1
Protocol to establish a stable _AML mouse model.建立稳定 _AML 小鼠模型的方案。
STAR Protoc. 2022 Jul 18;3(3):101559. doi: 10.1016/j.xpro.2022.101559. eCollection 2022 Sep 16.
2
[Establishment of AML Mouse Model by Transplantation of Hematopoietic Cells from MLL-AF9 Transgenic Mice].[通过移植MLL-AF9转基因小鼠的造血细胞建立急性髓系白血病小鼠模型]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Oct;29(5):1369-1374. doi: 10.19746/j.cnki.issn.1009-2137.2021.05.001.
3
Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model.在MLL-AF9驱动的小鼠模型中,依赖Atg5的自噬促进急性髓系白血病的发展。
Cell Death Dis. 2016 Sep 8;7(9):e2361. doi: 10.1038/cddis.2016.264.
4
MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.MLL-AF9与FLT3在急性髓性白血病中的协同作用:一种用于快速治疗评估模型的建立
Leukemia. 2008 Jan;22(1):66-77. doi: 10.1038/sj.leu.2404951. Epub 2007 Sep 13.
5
Murine Retrovirally-Transduced Bone Marrow Engraftment Models of MLL-Fusion-Driven Acute Myelogenous Leukemias (AML).MLL融合驱动的急性髓系白血病(AML)的小鼠逆转录病毒转导骨髓移植模型
Curr Protoc Pharmacol. 2017 Sep 11;78:14.42.1-14.42.19. doi: 10.1002/cpph.28.
6
[Effect of ADAR1 on the development of MLL-AF9 induced murine AML].ADAR1对MLL-AF9诱导的小鼠急性髓系白血病发生发展的影响
Zhonghua Xue Ye Xue Za Zhi. 2015 May;36(5):383-8. doi: 10.3760/cma.j.issn.0253-2727.2015.05.006.
7
ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia.ALOX5 在 MLL 重排白血病中表现出抗肿瘤和增敏作用。
Sci Rep. 2017 May 12;7(1):1853. doi: 10.1038/s41598-017-01913-y.
8
Integrated transcriptomic and epigenetic data analysis identifiesaberrant expression of genes in acute myeloid leukemia with MLL‑AF9 translocation.整合转录组和表观遗传数据分析鉴定出 MLL-AF9 易位的急性髓系白血病中基因的异常表达。
Mol Med Rep. 2020 Feb;21(2):883-893. doi: 10.3892/mmr.2019.10849. Epub 2019 Nov 26.
9
[Prognostic significance of detecting MLL-AF9 fusion gene expression in patients with acute myeloid leukemia by real-time fluorescence quantitative PCR].实时荧光定量PCR检测急性髓系白血病患者MLL-AF9融合基因表达的预后意义
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Dec;21(6):1435-40. doi: 10.7534/j.issn.1009-2137.2013.06.013.
10
Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapy.瞬时电位受体褪黑素2(Trpm2)不影响小鼠MLL - AF9驱动的急性髓系白血病(AML)白血病发生或体外化疗反应。
Exp Hematol. 2016 Jul;44(7):596-602.e3. doi: 10.1016/j.exphem.2016.03.006. Epub 2016 Mar 24.

引用本文的文献

1
Identification of CD84 as a potent survival factor in acute myeloid leukemia.鉴定CD84为急性髓系白血病中的一种有效生存因子。
J Clin Invest. 2025 Apr 8;135(11). doi: 10.1172/JCI176818. eCollection 2025 Jun 2.
2
DNAJC10 maintains survival and self-renewal of leukemia stem cells through PERK branch of the unfolded protein response.DNAJC10 通过未折叠蛋白反应的 PERK 分支维持白血病干细胞的存活和自我更新。
Haematologica. 2024 Mar 1;109(3):751-764. doi: 10.3324/haematol.2023.282691.

本文引用的文献

1
Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2.阿片受体信号通过 TET2 的催化和非催化功能抑制白血病。
Cell Rep. 2022 Jan 25;38(4):110253. doi: 10.1016/j.celrep.2021.110253.
2
Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia.靶向抑制 STAT/TET1 轴作为急性髓系白血病的治疗策略。
Nat Commun. 2017 Dec 13;8(1):2099. doi: 10.1038/s41467-017-02290-w.
3
Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles.
使用FLT3配体靶向的miR-150纳米颗粒根除急性髓系白血病
Cancer Res. 2016 Aug 1;76(15):4470-80. doi: 10.1158/0008-5472.CAN-15-2949. Epub 2016 Jun 8.
4
Delineating the effects of 5-fluorouracil and follicle-stimulating hormone on mouse bone marrow stem/progenitor cells.描绘5-氟尿嘧啶和促卵泡激素对小鼠骨髓干/祖细胞的影响。
Stem Cell Res Ther. 2016 Apr 19;7(1):59. doi: 10.1186/s13287-016-0311-6.
5
Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia.MLL 融合/MYC/LIN-28 阻断 miR-150 的成熟是 MLL 相关白血病所必需的。
Cancer Cell. 2012 Oct 16;22(4):524-35. doi: 10.1016/j.ccr.2012.08.028.